A miR-200b–Filamin A axis drives epicardial contribution to cardiogenesis Authors: Cristina Sánchez-Fernández, Carlos García-Padilla, Estefanía Lozano-Velasco,, Francisco Hernandez-Torres, Óscar Ocaña, Ana Quintas, Enrique Vázquez, Laura Alonso-Herranz, Mercedes Ricote, Beatriz Román-Payan, Rita Carmona, Diego Franco, Jorge N Domínguez, Amelia E Aránega Published: 2026 ABSTRACT AbstractThe epicardium provides essential cellular and molecular cues required for proper cardiogenesis and cardiac repair. Epicardial-derived cells (EPDCs) play a pivotal role in establishing cardiac structure, contributing to coronary vasculature formation, connective tissue organization, and post-ischemic cardiac remodeling. During EPDC emergence, the epicardium must preserve a precise balance between cellular motility and epithelial integrity. However, the mechanisms determining why some epicardial cells undergo epithelial-to-mesenchymal transition to become EPDCs while others retain an epithelial state remain unclear. We show that miR-200b is expressed in a subset of epicardial cells during embryonic EPDC formation. Gain-and loss-of-function experiments reveal that miR-200b regulates the overall number of EPDCs by modulating the proportion of symmetric and asymmetric cell divisions. RNA pull-down coupled with RNA-seq, together with in vitro and ex vivo functional assays, identified filamin A (FLNA)—a key regulator of spindle positioning during asymmetric division—as a direct miR-200b target in epicardial cells. FLNA loss reduced asymmetric divisions, supporting its role in promoting this division mode. Overall, our study defines a miR-200b–FLNA axis that governs symmetric versus asymmetric division to control epicardial tissue dynamics during cardiogenesis. Additionally, altered miR-200b expression after myocardial infarction in mice and humans suggests a potential role post-MI.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-026-52312-1.Keywords: Epicardium, EPDCs, miR-200b, FLNASubject terms: Cardiology, Cell biology Introduction The outermost cell layer of the vertebrate heart, the epicardium, comprises a population of multipotent progenitor cells that serve as a source of both cells and molecular signals essential for proper cardiac morphogenesis. During heart development, a subset of epicardial cells undergoes an epithelial-to-mesenchymal transition (EMT) between embryonic days E12.5 and E15.5 in mice, migrating into the myocardium as epicardial-derived cells (EPDCs)1,2. Within the myocardium, EPDCs give rise to multiple cardiac cell types, including coronary vascular smooth muscle cells, cardiac fibroblasts, endothelial cells, and possibly a subpopulation of cardiomyocytes, thereby contributing to complete heart formation3–6. After birth, the epicardium remains largely quiescent; however, EPDC formation can be reactivated following cardiac injury, contributing to the remodeling of the damaged myocardium7–10. Despite the central role of EPDC generation in both development and disease, the mechanisms determining why only a subset of epicardial cells undergo EMT while others retain their epithelial identity remain poorly understood. Previous studies have shown that cell division in the epicardium occurs in two distinct orientations, with perpendicular divisions aligning with the pattern of EPDC formation during development11. However, the molecular mechanisms governing this process remain unknown11,12. Over the past decades, extensive analyses of the EMT process have revealed additional layers of gene regulation, including post-transcriptional control by microRNAs (miRNAs). Among these, the miR-200 family has emerged as a key regulator of EMT, acting by repressing transcription factors such as SNAIL, TWIST, and ZEB, which orchestrate the epithelial-to-mesenchymal switch. This miRNA family also plays a crucial role in maintaining epithelial identity and preventing aberrant mesenchymal transition13–17. Recent studies have further shown that the miR-200 family modulates gene dosage of multiple transcription factors during early murine heart development; however, its specific function in the epicardium remains unclear18. In this study, we investigate the molecular mechanisms by which miR-200b regulates epicardial cell behavior during cardiogenesis. We identify a subpopulation of miR-200b–expressing cells in the epicardium, restricted to the developmental window of EMT. Through RNA pull-down, RNA sequencing, and gain- and loss-of-function assays, we demonstrate that miR-200b targets Filamin A (FLNA) in epicardial cells, and that FLNA levels influence the frequency of asymmetric cell divisions, from the epicardial epithelial sheet as inferred from division orientation and position. Furthermore, we show that miR-200b expression is altered in murine infarcted hearts and in blood samples from patients. Material and methods Cell lines, animals and human samples The MEC1 mouse embryonic epicardial cell line (SCC187, Merck Millipore) was stored and cultured according to the manufacturer’s instructions. This immortalized cell line does not express myocardial or endothelial markers and retains the morphology of early primary epicardial cells. The NIH/3T3 (CRL-1658, ATCC) cell was cultured following the manufacturer´s recommendations. The mWt1/IRES/GFP-Cre mouse line (hereafter WT1Cre) has been used in previous studies to trace Wt1 lineages19,20. For lineage tracing experiments, WT1Cre mice were crossed with homozygous Rosa26-EYFP [B6.129 × 1-Gt(ROSA)26Sortm1(EYFP)Cos/J] mice21, allowing permanent reporter expression in WT1-expressing cell lineages. WT1Cre-YFP mice were kindly provided by the laboratory of Ramón Muñoz-Chapuli (University of Málaga, UMA). Procedures involving CD1 (Janvier Labs) mouse embryos were approved by the Ethics Committee on Animal Experimentation of the University of Jaén (UJA) and performed in compliance with national and European guidelines for animal care and handling in the facilities of the UJA and the University of Granada (UGR). Additionally, 2 to 3-month-old male and female C57BL/6 mice (Charles River) were included in the study to undergo myocardial infarction (MI) procedures. These animals were conducted in accordance with European Union (EU) Directive 2010/63/EC, enforced in Spanish law under Real Decreto 53/2013. Mice were maintained under standard conditions (12 h light/dark cycle, 22 ± 0.1 °C, 50–55% humidity) with ad libitum access to food (AIN-93G diet) and water. WT1Cre-YFP, CD1, and C57BL/6 J mice were bred, and embryos were collected at embryonic days (E11.5 to E16.5). Human blood samples were obtained with informed consent from the participants or their legal guardians. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki (1975) and approved by the Ethics Committees of the University of Jaén and Hospital Universitario Virgen de las Nieves in Granada. Mouse and human sample collection and processing Pregnant female mice were euthanized by cervical dislocation. Embryonic hearts were then carefully isolated and dissected using fine forceps and a micro-scalpel. Collected embryonic tissues were fixed in 4% paraformaldehyde (PFA), washed with 1 × phosphate-buffered saline (PBS), cryoprotected through a series of increasing PBS-sucrose concentrations, and subsequently frozen in liquid nitrogen-cooled isopentane (PanReac AppliChem, 143501.1611) for sectioning. For histological analysis, tissues were sectioned at 10 µm thickness using a cryostat microtome (CM1510S, Leica) and mounted on Epredia™ SuperFrost Ultra Plus Adhesion Slides (10149870, Fisher Scientific). Human blood samples from patients with myocardial infarction were centrifuged at 3000 rpm for 15 min at 4 °C to obtain plasma. RNA isolation (mRNA and miRNA), cDNA synthesis and RT-qPCR Total RNA from cardiac explants and transfected cells was extracted using the ReliaPrep™ RNA Cell Miniprep System (Promega, Z6011) according to the manufacturer’s instructions. RNA concentration was measured using 1.5 µL of each sample on a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific). For miRNA isolation from human plasma, the miRNeasy Serum/Plasma Advanced Kit (Qiagen, 217204) was used following the manufacturer’s protocol. For miRNA reverse transcription, 10 ng of total RNA was used as a template with the miRCURY LNA Universal RT Kit (Qiagen, 203301). For mRNA analysis, 500 ng of total RNA was reverse transcribed using the Maxima First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, K1642) on a Bio-Rad C1000 Touch™ Thermal Cycler, according to the manufacturer’s instructions. At least three independent pooled samples were used for each RT-qPCR experiment. miR-200b expression was quantified by real-time quantitative PCR (RT-qPCR) using diluted cDNA and the GoTaq qPCR Master Mix (Promega, A6001) on a CFX Connect Real-Time PCR Detection System (Bio-rad C1000 Touch™ Thermal Cycler) in line with the manufacturer’s instructions. In all cases, at least three distinct pooled samples were used to perform the corresponding RT-qPCR experiments. The expression levels of miR-200b were quantified by real-time semi-quantitative PCR (RT-qPCR) using diluted cDNA obtained from the reverse transcription reaction, following the GoTaq qPCR Master Mix protocol (Promega; A6001). All RT-qPCR reactions were performed on a CFX Connect Real-Time PCR Detection System (Bio-Rad Laboratories) according to the manufacturer’s instructions. The cycling program consisted of an initial denaturation at 95 °C for 10 min, followed by 40 cycles of 95 °C for 5 s (denaturation) and 60 °C for 1 min (annealing and extension). Melt curves were generated with an initial step at 95 °C for 5 s, followed by 0.5 °C increments every 7 s from 65 to 95 °C. miR-200b expression was normalized to U6 snRNA and 5S rRNA, and relative expression levels were calculated as the ratio of miR-200b to the reference RNAs. Primers used for miRNA qPCR are listed in Table 1. Table 1Primers used for the miRNA qPCR.GeneSource, identifierhsa-miR-200b-3p miRCURY LNA miRNA PCR AssayQiagen, YP002060715S rRNA (hsa) miRCURY LNA miRNA PCR AssayQiagen, YP00203906U6 rRNA (hsa) miRCURY LNA miRNA PCR AssayQiagen, YP00203907 Primers used for the miRNA qPCR. For mRNA quantification, RT-qPCR was performed using the SoFast™ EvaGreen® Supermix kit (Bio-Rad; 1725201) on a CFX Connect Real-Time PCR Detection System (Bio-Rad Laboratories). The qPCR program included an initial denaturation at 95 °C for 3 min, followed by 45 cycles of 95 °C for 15 s (denaturation), 60 °C for 45 s, and 75 °C for 7 s (annealing and extension). Melt curves were generated by an initial step at 95 °C for 5 s, followed by 0.5 °C increments every 7 s from 65 to 95 °C. Relative gene expression levels were calculated using the 2−ΔΔCt method22, with Gapdh or GusB as internal controls. These housekeeping genes were validated for stable expression across samples. Primers used for mRNA qPCR are listed in Table 2. Table 2Primers used for the mRNA qPCR.GeneOrganismForward primer (5´to 3´)Reverse primer (5´to 3´)Flna (NM_00129042.1)Mus musculusGCTAAGCAAGGCTTATGTA GGGCTGCCCATGTGTTTCACCGusB (NM_010368.1)Mus musculusACGCATCAGAAGCCGATTA TACTCTCAGCGGTGACTGGTTGapdh (NM_008084.2)Mus musculusGGCATTGCTCTCAATGACA ATGTGAGGGAGATGCTCAGTG Primers used for the mRNA qPCR. All PCR reactions were performed in triplicate and repeated using at least three independent biological samples to obtain representative averages. Fluorescence in situ hybridization (FISH) FISH for miR-200b was performed on cryosections of hearts from WT1Cre-YFP mouse embryos (E11.5–E16.5). Sections were first washed for 10 min with 0.03% H₂O₂ in PBS to block endogenous peroxidase activity, followed by permeabilization in 2% acetone/PBS for 5 min. After a single wash with 30% formamide/2 × saline-sodium citrate (SSC) buffer (300 mM NaCl, 30 mM Na₃Citrate·2H₂O, pH 5) for 10 min, pre-hybridization was performed for 30 min at 48 °C using a hybridization mix containing 50% formamide, 1.3 × SSC, 0.5 mg/mL yeast tRNA, 0.2 × CHAPS, 0.5 M EDTA (pH 8), and 0.2% Tween-20. Hybridization was carried out with 25 nM hsa-miR-200b-3p double DIG-labeled LNA probe (Qiagen; 33,911 YD00619853-BCG) diluted in hybridization mix at 48 °C for 2 h 30 min. Sections were then washed sequentially in 2 × SSC and 1 × SSC at 48 °C, with a final wash at room temperature (RT). Sections were rinsed in 1 × PBS prior to signal amplification using either the Alexa Fluor Tyramide SuperBoost Kit (Invitrogen; B40943 or B40912) or TSA Plus Cyanine 5 (Akoya Biosciences; NEL745001KT). Samples were blocked for 1 h with Blocking Buffer (Invitrogen) and rinsed three times with 1 × PBS. The appropriate anti-DIG antibody (Invitrogen; rabbit 9H27L19 or mouse ab420) was applied at 5 µg/mL in Blocking Buffer and incubated overnight at 4 °C. The next day, sections were rinsed three times with 1 × PBS and incubated with the corresponding poly-HRP-conjugated secondary antibody (Invitrogen; rabbit B40943 or mouse B40912) at RT for 60 min. Following three washes in 1 × PBS, Tyramide Working Solution was added for 8 min at RT according to the manufacturer’s instructions. The reaction was stopped with Stop Reagent for 30 s, and sections were rinsed in 1 × PBS prior to subsequent immunostaining. Images were acquired using a Leica TCS SPE-CTR6500 LAS AF confocal microscope, and analysis was performed with ImageJ (version 1.54 of ImageJ (National Institutes of Health); https://imagej.nih.gov/ij/). Images were obtained over the full extent of the epicardium in each sample. FACS analysis Previously described WT1Cre/Rosa26R-EYFP mice were used in this study. WT1Cre-YFP + mice display permanent YFP reporter expression in the Wt1 cell lineage; WT1 driven eYFP expression is a bona fide marker for epicardium and epicardial-derived cells22. Pregnant Homozygote (Cre+/+) female mice (crossed with Rosa26R-EYFP) were harvested at E13.5. E13.5 hearts were manually dissected. For flow cytometry analysis and sorting, dissected hearts from E13.5 embryos were placed in cytometry buffer (phosphate buffer saline (PBS) plus 2% fetal bovine serum (FBS) and 10 mM 4-(2-hydroxyethyl)- 1-piperazineethanesulfonic acid (HEPES)) and homogenized by repeated pipetting. Cell suspension was washed by pelleting at 400G during 5 min. Then, cells were incubated at 4ºC in darkness with the fluorochrome conjugated antibodies: anti-CD31-APC (PECAM-1) (Table 3) for general staining of the endothelium. 4′,6-Diamidine-2′-phenylindole dihydrochloride (DAPI; Thermo Fisher Scientific; D1306; RRID: AB_2629482) staining was included to exclude dead cells. Negative controls (GFP negative littermates) and isotypic antibody allowed setting of the gates (Table 3). Epicardial cells were then sorted by YFP high fluorescence and lack of CD31 staining5. Cells were sorted in a BD FACS Aria Fusion Cell Sorter. Data were analyzed with FlowJo TM10. After sorting, epicardial cells were pooled and stored in buffer lysis for RNA isolation at − 80 °C until used. At least 3–5 litters were used at each developmental stage until sufficient tissue was collected, which would guarantee optimal and sufficient RNA isolation for further sequencing. Table 3Antibodies used for FACS.AntibodiesSourceIdentifier or Catalog numberMouse monoclonal anti-CD31-APC (PECAM-1)Thermo Fisher17-0311-82Rat FITC IgG2a K isotypeBiolegend400505 Antibodies used for FACS. Embryonic cardiac explant culture Hearts from mice embryos were isolated at the developmental stages E12.5 and E14.5 and cleaned on a dish with 1 × PBS. After removing cardiac atria, ventricles were placed inverted on the culture plate, previously treated with collagen (Corning™ 354236; #11563550), cultured in DMEM (Gibco™ DMEM high 10 glucose, no glutamine; #11960044) supplemented with 10% Fetal bovine serum (onward FBS; Sigma-Aldrich, F7520) and 2% penicillin/streptomycin (Sigma-Aldrich; P0781) and incubated at 37 °C, 5% CO2. After 24 h in culture, ventricles were used to perform miR-200b gain- and loss-of-function experiments (premiR-200b and antimiR-200b transfection). Cell culture and tissue premiR and antimiR transfections MEC1 cell line and embryonic cardiac explants were transfected with mirVana miRNAs: pre-miR miRNA precursor (hsa-miR-200b-3p; PM10492, Life Technologies), Scramble (Thermo; #4464077) and anti-miR miRNA inhibitor (hsa-miR-200b-3p; AM10492, Life Technologies) using Lipofectamine-2000 (Invitrogen™ Lipofectamine™ 2000 Transfection Reagent; Thermo Fisher Scientific, Carlsbad, CA, USA #11668030) and optiMEM medium (Opti-MEM™; Gibco™ #31985047) following the manufacturer’s instructions. After 24 h, cells were collected for RNA extraction, RT-qPCR analysis and immunohistochemistry assays. Immunostaining and fluorescence intensity quantification For immunocytochemistry, MEC1 cells were seeded in 4-chamber glass-bottom dishes (Cellvis; NC0832919) and treated with scramble, premiR-200b, or antimiR-200b. Cells were fixed with 4% PFA for 10 min, permeabilized in PBS containing 0.25% Triton X-100 and 50 mM NH₄Cl for 10 min at room temperature (RT), and blocked with PBS-0.2% gelatin (Sigma-Aldrich; G1393) for 20 min at RT. Primary antibodies (Table 4) were applied at 5–10 µg/mL in blocking solution and incubated overnight at 4 °C in a humidified chamber. After washing, Alexa Fluor-conjugated secondary antibodies (Table 4) diluted 1:200 in blocking solution were added for 30 min at RT in the dark. Nuclei were counterstained with DAPI. Images were acquired using a Leica TCS SPE-CTR6500 LAS AF confocal microscope, and quantification was performed with ImageJ software (version 1.54 of ImageJ (National Institutes of Health); https://imagej.nih.gov/ij/). Table 4Antibodies used for immunostaining.AntibodiesSourceConcentration/dilutionIdentifier or Catalog numberRabbitAnti-Filamin A [EP2405Y]Abcam1/100Ab76289Rabbit Anti-Aurora Kinase BAbcam1/100Ab2254Digoxigenin Recombinant Rabbit Monoclonal AntibodyInvitrogen™5 µg/mL9H27L19Alexa Fluor® Goat anti-rabbit 633Thermo Fisher Scientific1/200A-21070; RRID: AB_2535732 Antibodies used for immunostaining. Rabbit Anti-Filamin A [EP2405Y] For immunohistochemistry, cryosectioned samples were equilibrated to RT and incubated in TBSA-BSAT (10 mM Tris, 0.9% NaCl, 0.02% sodium azide, 2% BSA, 0.1% Triton X-100) for 2 h at RT. Primary antibodies (Table 3) were applied at 5 µg/mL in TBSA-BSAT and incubated overnight at 4 °C in a humidified chamber. After washing, Alexa Fluor-conjugated secondary antibodies (1:200 in TBSA-BSAT) were applied for 2 h at RT in the dark. Nuclei were counterstained with DAPI (1:2000 in PBS; Thermo Fisher Scientific; D1306; RRID: AB_2629482) for 15 min at RT, and samples were mounted using Vectashield Antifade Mounting Medium (Vector Laboratories; H-1000–10). Images were acquired using a Leica TCS SPE-CTR6500 LAS AF confocal microscope, and analysis was performed with ImageJ (version 1.54 of ImageJ (National Institutes of Health); https://imagej.nih.gov/ij/). The corrected total fluorescence intensity of FLNA immunostaining was determined by subtracting background signal using ImageJ. For each condition (control, premiR-200b, or antimiR-200b) and animal (n = 3-5), at least 70 images were acquired using a 63 × water-immersion objective. Affinity pull-down of RNA assay To identify miRNA targets and provide experimental evidence of direct interaction between miR-200b and its mRNA targets, an affinity pulldown of biotinylated RNA approach was employed. Biotinylated miR-200b mimics (Premium miRNA Mimic; YM00472051-BDI) and scramble control miRNA (Premium miRNA Mimic; YM00479902-BDI) were synthesized and obtained from IDT Technologies, and delivered to epicardial cells via transfection. Transfected epicardial cells (2 × 105 per dish) were harvested 48 h post-transfection and lysed using the miRNeasy Tissue/Cells Advanced kit lysis buffer (Qiagen; 217604). Complexes of biotinylated RISC and associated mRNAs were captured using streptavidin-coated magnetic beads (Thermo Fisher Scientific; Dynabeads M-280, 11206D), with background reduction achieved via Argonaute immunoprecipitation. Following wash steps, the pulled-down RNA was purified and subjected to next-generation sequencing (RNA-seq) for target identification. RNA-sequencing (RNA-seq) A total of 2.5 ng of RNA was used to generate cDNA using the SMART-Seq v4 Ultra Low Input RNA Kit (Clontech-Takara). From this, 1 ng of amplified cDNA was used to prepare barcoded sequencing libraries with the Nextera XT DNA Library Preparation Kit (Illumina), in which cDNA fragmentation and adapter ligation occur in a single reaction, followed by amplification and cleanup. Library size was assessed using the Agilent 2100 Bioanalyzer High Sensitivity DNA chip, and concentrations were determined with a Qubit® fluorometer (Thermo Fisher Scientific). Libraries were sequenced on a HiSeq 2500 platform (Illumina), and base calling was performed with RTA v1.18.66.3. FastQ files for each sample were generated using bcl2fastq v2.20.0.422 (Illumina). Sequencing reads were aligned to the mouse reference transcriptome (mm10 v92) and quantified with RSEM v1.3.1. Raw counts were normalized using TPM (Transcripts per Million) and TMM (Trimmed Mean of M-values) methods, transformed to log2 expression values (log2(rawCount + 1)), and used to calculate fold changes and adjusted p-values. Differential expression was defined as Log2FC > 0.584 (1.5 ×) with adjusted p < 0.05. Only mRNAs detected in all three transcriptomes were included in the analysis. Luciferase activity assay FLNA 3´UTR construct was PCR-amplified and cloned into the pGLuc_pMIR-REPORT vector. Then, NIH/3T3 cells were co-transfected with 100 ng of the FLNA luciferase vector, 300 ng of pcLux vector control for internal normalization and 20 nm of Scramble or miR-200b mimic, respectively. Luciferase activity was measured 18 h after transfection by using the Pierce Gaussia Luciferase Flash Assay Kit (Thermo Fisher Scientific, Rockford, IL, USA) and normalized to pcLux vector control by using the Pierce Cypridina Luciferase Flash Assay Kit (Thermo Fisher Scientific, Rockford, IL, USA). PCR-based site-directed mutagenesis was performed using the Bio-Rad iPROOF PCR kit. Primers, including MD200b_FLNA_Fw (5′-AAGAGGAATAAAATTTTG-3′), MD200b_FLNA_Rv (5′-CAAAATTTTATTCCTCTT-3′). CTG original nucleotides were mutated by AAA nucleotides (cursive letters). The underlined nucleotides are referenced to nucleotides changed in site-directed mutagenesis and were used to introduce mutations into the sequence complementary to seed sequences of miR-200b within the 3′ UTRs of FLNA. Each luciferase assay was carried out in triplicate and repeated in at least three distinct biological samples to obtain representative means. Tissue electroporation Loss-of-function of miR-200b was induced in mouse embryonic hearts following the protocol described by Mañes-García et al.23. Embryonic hearts from C57BL/6 J mice at E14.5 were exposed and placed in a Petri dish containing warm 1 × PBS. Hearts were incubated in an electroporation mixture consisting of 6% sucrose in 1 × PBS. To ensure efficient delivery, multiple injections of pre-miR-200b precursor (hsa-miR-200b-3p; PM10492, Life Technologies), scramble control (Thermo; #4464077), or anti-miR-200b inhibitor (hsa-miR-200b-3p; AM10492, Life Technologies) were performed. Electroporation was carried out with the heart positioned between electrodes using the following parameters: 5 cycles of 50 ms at 40 V with 900 ms intervals (Nepa Gene, CUY664-10X15 and CUY650P5). Following electroporation, hearts were incubated at 37 °C with 5% CO₂ for 24 h. Cy5-FLNA siRNA cotransfection CD1 mice were bred and embryos were collected at embryonic developmental stage E12.5. Embryonic hearts were isolated and cultured in DMEM/F-12 supplemented with 12,5% of Horse Serum and 200 nM of L-glutamine at 37 °C in a humidified atmosphere of 5% CO2. Two experimental groups were performed: 1) Control group transfected with a 60 nm of MISSION® siRNA Fluorescent Universal Negative Control #1, Cyanine 5 (Sigma, Aldrich, Munich, Germany) as transfection efficiency control and 2) FLNA group transfected with a 60 nm of FLNA siRNA (Sigma, Aldrich, Munich, Germany) plus 60 nm of MISSION® siRNA Fluorescent Universal Negative Control #1, Cyanine 5 (Sigma, Aldrich, Munich, Germany). All transfections were carried out with Lipofectamine 2000 (Invitrogen™ Lipofectamine™ 2000 Transfection Reagent; Thermo Fisher Scientific, Carlsbad, CA, USA #11,668,030) following the manufacturer’s guidelines in antibiotic-free medium for 36 h. siRNA sequences are provided in Table 5. Validation of FLNA inhibition was performed by RT-qPCR assays. After the transfection period, hearts were washed twice in cold 1xPBS and fixed in 4% PFA for 1 h at room temperature, followed by sucrose cryoprotection before embedding in OCT media. Table 5FLNA siRNA sequence.GeneSequenceFLNA-senseGCCCAGCAGAGUUUAUUGU-rU-rUFLNA-antisenseACAAUAAACUCUGCUGGGC-rU-Ru FLNA siRNA sequence. Mouse model of myocardial infarction (MI) Two- to three-month-old male and female C57BL/6 mice (Charles River) were used for all experiments. Myocardial infarction (MI) was induced by permanent ligation of the left anterior descending (LAD) coronary artery, following established protocols24. The average preoperative weight of the mice was 27.00 ± 4.23 g. Briefly, mice were anesthetized with sevoflurane (5% for induction, 2–3% for maintenance) and intubated using a blunt-tipped 24-gauge intravenous catheter. Mechanical ventilation was maintained with a rodent ventilator (Minivent 845) delivering a 1:1 mixture of oxygen and air at 160 breaths per minute and a tidal volume of 250 µL. Body temperature was kept at 37 °C using a heating pad. A left thoracotomy was performed at the fourth intercostal space to expose the heart. After incision of the pericardium, the proximal LAD was visualized and permanently ligated using a 7–0 silk suture (Lorca Marín). The chest wall and skin were closed with 6–0 silk sutures (Lorca Marín). Postoperative analgesia was provided with buprenorphine (0.01 mg/kg; Buprex, Merck). Mice were euthanized at 1, 3, 7 or 14 days post-MI via CO₂ inhalation. Sham-operated animals were used as physiological controls (day 0). Statistical analysis All statistical analyses were conducted by Statgraphics Centurion (version 19) and GraphPad Prism (version 10.2.0 (341) of the GraphPad Software, LLC; https://www.graphpad.com/). Data were obtained from independent experiments performed in triplicate and are presented as mean ± standard deviation. The number of independent experiments (n) is specified in the corresponding figure legends. Differences between two groups were analyzed using the unpaired Student’s t test. When more than two groups were compared, one-way ANOVA followed by Dunnett´s post hoc test was performed. Results miR-200b is expressed in a subset of cells within epicardial epithelial layer in the developing heart The embryonic epicardium originates from the proepicardium (PE), a cluster of mesothelial cells initially located external to the heart that subsequently spreads across the myocardial surface to form a continuous outer layer, the epicardium2. Following this process, a subset of epicardial cells undergoes epithelial-to-mesenchymal transition (EMT), generating cell populations that play essential roles in cardiac development. However, the mechanisms determining why certain epicardial cells transition into epicardium-derived cells (EPDCs) while others remain within the epithelial sheet are not fully understood. The loss of epithelial markers and acquisition of mesenchymal traits are key steps in EMT, and these processes have been reported to be regulated by members of the miR-200 family in various biological contexts. In this regard, previous RNA-seq analyses from our laboratory revealed that miR-200b is differentially expressed during the transition from PE to the early embryonic epicardium, but did not significantly influence EMT marker expression (such as Snail or Prrx1) in epicardial cell cultures. These findings suggest that the role of miR-200b in the epicardium may not be directly related to the epicardial-to-mesenchymal transition25. To further elucidate the function of miR-200b within the epicardial layer, we first analyzed its expression pattern at different stages of murine heart development by RT-qPCR. As shown in Fig. 1A, and in comparison with other miRNAs involved in cardiac development such as miR-1 and miR-133, miR-200b expression was first detected in the embryonic heart at E12.5, reached its maximum at E15.5, and became undetectable by E16.5. These results indicate that miR-200b expression is restricted to a specific developmental window during which the epicardium actively contributes to cardiac morphogenesis. miR-200b is expressed in a subset of epicardial cells during EPDCs emergence in the developing heart. (A) Transcript levels of miR-200b, miR-1 and miR-133a in the developing mouse heart from E10.5 to E16.5. Error bars indicate SD. n = 3; each point represents averaging of three technical replicates. Statistical analysis was performed using a one-way ANOVA followed by Dunnett’s multiple comparisons test. (B) Representative FISH images showing miR-200b expression across different epicardial regions at high magnification (63 × objective) in embryonic heart sections from WT1Cre-YFP mouse embryos at E12.5, E14.5, and E15.5. To provide anatomical context for the high-magnification images, a representative reconstruction of a whole E12.5 heart, generated from low-magnification images (4 × objective), is included. In the low-magnification image, three boxed regions represent the areas from which high-magnification images were acquired at E12.5, E14.5, and E15.5, corresponding to panels B′, B″, and B. The basement membrane is delineated by a dotted line marking the boundary between the epicardial layer (YFP⁺) and the underlying subepicardium and outer myocardium containing EPDCs (YFP⁺). Arrows indicate miR-200b expression. Scale bars: 50 μm. LA: Left atrium, LV: Left ventricle, RA: Right atrium, RV: Right ventricle. (C) Quantifications of miR-200b + / YFP + cells versus total YFP + cells in the epicardial sheet at E12.5, E13.5, E14.5 and E15.5 developmental stages. Error bars indicate SD. n = 10–25. Statistical analysis was performed using a one-way ANOVA followed by Dunnett´s multiple comparisons test. Analysis of the entire epicardium showed no regional differences in miR-200b⁺ cell numbers at any stage. (D) Quantifications of epicardial-derived cells (YFP+ cells) internalized into the subepicardium and the outer myocardial layers in the embryonic heart at E12.5, E13.5, E14.5 and E15.5 stages of development. Error bars indicate SD. n = 4–14. Statistical analysis was performed using a one-way ANOVA followed by Dunnett´s multiple comparisons test. (E) Scheme of epicardial-YFP+ cells collection from WT1Cre-YFP mouse embryonic heart at E13.5 by FACS. (F) Transcript levels of miR-200b in cell sorted YFP+ and YFP- cells. Error bars indicate SD. n = 3–4; each point represents averaging of three technical replicates. Statistical analysis was performed using the unpaired Student’s T-test. To examine miR-200b expression in epicardial cell populations associated with EPDC emergence, we used WT1Cre-eYFP reporter mice, in which YFP is permanently expressed in the WT1 cell lineage26. Since WT1 is widely recognized as a key marker of the embryonic epicardium, WT1-driven eYFP expression enables the identification of epicardial and epicardium-derived cells26. miR-200b LNA in situ hybridization in WT1Cre-eYFP embryos demonstrated that miR-200b expression was restricted to YFP⁺ epicardial cells throughout the entire epicardial layer (Fig. 1B). Expression of miR-200b was first detected at E12.5 and was confined to a subset of cells within the epicardial layer. The number of miR-200b⁺ cells increased at E13.5 and E14.5, with the highest proportion observed at E15.5 (Fig. 1B,C). In contrast, no miR-200b⁺ cells were detected at E11.5 or E16.5 (Supplementary Fig. 1). During the developmental window associated with elevated miR-200b expression (E12.5–E15.5), the number of EPDCs undergoing internalization into the myocardium markedly increased, as inferred from WT1-Cre–driven YFP labeling and their anatomical localization (Fig. 1C,D). Notably, miR-200b levels peaked at E15.5, coinciding with the onset of a decline in EPDC-YFP+ numbers; by E16.5, EPDC-YFP+ internalization was no longer detectable, consistent with the completion of EPDC emergence (Fig. 1A, C,D). Collectively, these findings support a regulatory role for miR-200b in modulating epicardial dynamics during EPDC emergence. To further confirm miR-200b expression in epicardial cells, YFP⁺ cells were isolated from the hearts of WT1Cre-eYFP embryos at E13.5 by fluorescence-activated cell sorting (FACS), and miR-200b levels were quantified by RT-qPCR (Fig. 1E,F). As shown in Fig. 1F, YFP⁺ cells exhibited significantly higher levels of miR-200b compared with YFP⁻ cells, reinforcing the conclusion that miR-200b is expressed in embryonic epicardial cells. Altogether, these results demonstrate that miR-200b is expressed in a subset of epicardial cells during the developmental stages associated with EPDCs emergence from the epicardium. miR-200b regulates EPDCs generation by modulating mitotic spindle orientation in epicardial cells To further investigate the function of miR-200b in the epicardium, we sought to evaluate its involvement in the emergence of EPDCs from the epicardial layer. To this end, ex vivo gain- and loss-of-function experiments were performed by transfecting premiR-200b or antimiR-200b molecules into E12.5 WT1Cre-YFP embryonic heart explants (Fig. 2A,B). Following 24 h of premiR-200b transfection, the number of YFP⁺ EPDCs observed within the myocardium was markedly reduced compared to control (Scramble-treated) explants (Fig. 2C,D). Conversely, antimiR-200b–treated heart explants exhibited a significant increase in YFP⁺ cells that had migrated into the myocardium (Fig. 2C,D). These findings indicate that miR-200b inhibits EPDCs formation and subsequent myocardial invasion, suggesting that this miRNA modulates the generation of EPDCs from the embryonic epicardium. miR-200b gain- and loss-of-function modifies EPDCs generation from the embryonic epicardium. (A) Scheme of miR200b gain- and loss-of-function experiments, by transfection of premiR-200b and antimiR-200b molecules, in embryonic heart explants isolated from WT1Cre-YFP mice. (B) Transcript levels of miR-200b in the embryonic heart explants after premiR-200b and antimiR-200b transfections. Error bars indicate SD. n = 3. Each point represents the mean of three technical replicates. Statistical analysis was performed using a one-way ANOVA followed by Dunnett´s multiple comparisons test. (C) Representative images of epicardial and epicardial-derived cells (YFP+ cells) in the embryonic heart explants transfected with premiR-200b, antimiR-200b and scramble-control molecules. The boundary between the epicardium and the myocardium has been delineated with a dotted line. White arrows indicate EPDCs. Scale bars: 50 μm. (D) Quantifications of the percentage of epicardial-derived cells (YFP+ cells) internalized into the myocardium in the embryonic heart explants transfected with premiR-200b, antimiR-200b and scramble control molecules. Error bars indicate SD. n = 4–14. Each point displayed in the graph represents a single quantified image obtained from independent biological samples. Each colour represents an independent biological replicate. Statistical analysis was performed using the biological sample as the unit of analysis; with measurements from multiple images per sample averaged prior to comparison. Differences among groups were assessed by one-way ANOVA followed by Dunnett´s multiple comparisons test. Previous studies have demonstrated that mitotic spindle orientation plays a critical role in regulating epicardial cell entry into the myocardium. In the embryonic epicardium, symmetric cell divisions give rise to two daughter cells that both remain within the epithelial layer, whereas asymmetric divisions, oriented perpendicularly to the basement membrane, contribute to generate EPDCs11 (Fig. 3A,B). In agreement with prior observations by Wu et al. (2010), we found that both division types occur between E12.5 and E14.5, with asymmetric divisions predominating at E13.5 (Fig. 3C). By E15.5, corresponding to the completion of EMT, mitotic spindles in dividing epicardial cells were predominantly oriented symmetrically (Fig. 3C). miR-200b alters mitotic spindle orientation in the embryonic epicardium. (A) Scheme for symmetric and asymmetric cell division analysis criteria in the epicardial cells. The polar chart illustrates how the orientations of epicardial cell spindles were quantified. The basement membrane was considered 0° and is represented by the black dotted line. Each line corresponds to the spindle orientation of a dividing epicardial cell. Divisions with spindle orientations between 30° and 330° were classified as symmetric, whereas those between 60° and 120° were classified as asymmetric. (B) Representative image of symmetrical (dashed arrow) and asymmetrical cell division (arrow) in the epicardial layer. Scale bars, 25 μm. The basement membrane is indicated by a dotted line. (C) Ratio of epicardial cell spindle orientation in the embryonic epicardium, from E12.5 to E15.5. Error bars indicate SD. n = 3. (D) Scheme of gain- and loss-of-function experiments, by premiR-200b and antimiR-200b molecules transfection, in embryonic heart explants. (E) Transcript levels of miR-200b in embryonic transfected-heart explants. Error bars indicate SD. n = 3. Each point represents the mean of three technical replicates. Statistical significance was determined using a one-way ANOVA followed by Dunnett’s multiple comparisons test. (F) Representative images of symmetric (dashed arrow) or asymmetric cell division in epicardial cells in transfected embryonic heart explants. Aurora B staining was used to define spindle orientation. The basement membrane is indicated by a dotted line. The double-headed arrows indicate the orientation of the spindle. Scale bars: 25 μm. (G) Ratio of epicardial cell spindle orientation after miR-200b gain- and loss-of-function experiments in embryonic heart explants. Error bars indicate SD. n = 3–17. Proportions of symmetric and asymmetric divisions in each experimental group (premiR-200b or antimiR-200b) were compared against those observed in the scramble control group. Statistical analysis was performed using a one-way ANOVA followed by Dunnett´s multiple comparisons test. Given our earlier results showing that miR-200b overexpression suppresses EPDCs generation and myocardial internalization, we next examined whether miR-200b influences EPDCs formation by modulating epicardial mitotic spindle orientation. To address this, we performed additional gain- and loss-of-function experiments through ex vivo transfection of premiR-200b and antimiR-200b molecules into E12.5 heart explants (Fig. 3D,E). Subsequent Aurora B immunostaining was used to identify dividing epicardial cells (Fig. 3F). As shown in Fig. 3G, miR-200b overexpression significantly increased the proportion of symmetric divisions relative to control explants, whereas the fraction of asymmetric divisions decreased from approximately 40% to less than 20%. In contrast, antimiR-200b treatment enhanced the occurrence of asymmetric divisions compared to the scramble control. Moreover, miR-200b gain-of-function conditions led to a marked expansion of the symmetric division population (Fig. 3G). Collectively, these data suggest that miR-200b modulates the balance between symmetric and asymmetric divisions in the epicardial epithelium, thereby influencing EPDCs formation during heart development. miR-200b regulates symmetric/asymmetric divisions by targeting FLNA in epicardial cells To dissect the mechanism by which miR-200b controls symmetric versus asymmetric divisions in epicardial cells, we searched for mRNAs that physically interact with miR-200b. To address this, we conducted a biotinylated miR-200b RNA pull-down assay using the MEC1 mouse embryonic epicardial cell line, a well previously established in vitro model of epithelial epicardial cells27–29, followed by RNA sequencing (RNA-seq) (Fig. 4A). This approach enables high specificity by isolating RNAs that directly associate with miR-200b within the RISC complex, thereby identifying direct mRNA targets, unlike methods based solely on miRNA overexpression, which may yield indirect or secondary effects30. RNA-seq analysis identified 32 mRNAs specifically bound to miR-200b in MEC1 cells (Fig. 4B). Based on our previous findings, we focused on miR-200b targets potentially involved in regulating spindle orientation. Among these, Filamin A (FLNA) was of particular interest, as it has been shown to be essential for spindle migration and asymmetric division in mouse oocytes31. Moreover, FLNA loss-of-function causes severe cardiac septation defects, a process linked to both endothelial and epicardial EMT32. Notably, significant changes in Flna expression levels occur in the developing heart during the stages in which EMT takes place (Supplementary Fig. 2) and Luciferase reporter assays further validated Flna as a direct target for miR-200b (Fig. 4C). miR-200b targets FLNA in MEC1 epicardial cells. (A) Schematic representation of miR-200b target identification in MEC1 cell line by RNA pull-down. (B) miR-200b-binding mRNAs in MEC1 epicardial cells obtained by RNA-seq analyses after RNA pulldown. (C) Luciferase reporter assay assessing post-transcriptional regulation of the FLNA 3′UTR by miR-200b. Relative luciferase activity (arbitrary units, a.u.) was measured in 3T3 cells transfected with the FLNA 3′UTR construct alone (FLNA 3′UTR), co-transfected with miR-200b (FLNA 3′UTR + miR-200b), or co-transfected with a mutated 3′UTR construct and miR-200b (FLNA 3′UTR mut + miR-200b). Error bars indicate SD.n = 3. Statistical analysis was performed using the unpaired Student’s T-test. (D) Scheme of premiR-200b and antimir-200b transfection in MEC1 cells. (E) Transcript levels of miR-200b in MEC1 cells after premiR, antimiR and scramble-control transfections. Error bars indicate SD. n = 3. Each point represents the mean of three technical replicates. Statistical significance was determined using a one-way ANOVA followed by Dunnett’s multiple comparisons test. (F) Transcript levels of Flna in premiR-200b, antimiR-200b and scramble transfected MEC1 cells. Error bars indicate SD. n = 3. Each point represents the mean of three technical replicates. Statistical analysis was performed using a one-way ANOVA followed by Dunnett´s multiple comparisons test. (G) FLNA immunostaining from the scramble, premiR- and antimiR-200b treated MEC1 culture. For a clearer view, FLNA-staining is shown in both magenta and gray scale. Scale bars: 200 μm. (H) Quantification of corrected FLNA fluorescence intensity. Error bars indicate SD. n = 3–5. Each point displayed in the graph represents a single quantified image obtained from independent biological samples. Each colour represents an independent biological replicate. Statistical analysis was performed using the biological sample as the unit of analysis; with measurements from multiple images per sample averaged prior to comparison. Differences among groups were assessed by one-way ANOVA followed by Dunnett´s multiple comparisons test. To more thoroughly validate FLNA as a bona fide miR-200b target, we performed gain- and loss-of-function assays in MEC1 cells by transfecting pre-miR-200b or anti-miR-200b molecules (Fig. 4D,E). miR-200b overexpression significantly reduced Flna mRNA levels compared with scramble controls, whereas miR-200b inhibition markedly increased Flna expression (Fig. 4F). Consistent with these results, FLNA immunolabeling intensity decreased following pre-miR-200b transfection and increased in anti-miR-200b–treated cells relative to controls (Fig. 4G,H). Together, these findings indicate that miR-200b post-transcriptionally represses FLNA in epicardial cells and support a strong mechanistic link to the regulation of asymmetric divisions. To confirm this regulation in tissue, we conducted ex vivo gain- and loss-of-function assays by electroporating pre-miR-200b or anti-miR-200b into E14.5 embryonic heart explants (Fig. 5A,B). Consistent with our in vitro data, FLNA immunostaining intensity was significantly reduced after miR-200b overexpression, whereas anti-miR-200b–electroporated explants displayed FLNA levels comparable to scramble controls (Fig. 5C,D). Together, these results confirm that FLNA is post-transcriptionally regulated by miR-200b in the epicardial layer. miR-200b regulates FLNA expression in the epicardial layer. (A) Scheme of gain-and loss-of-function experiments, by premiR-200b, antimiR-200b and scramble-control molecules, in embryonic heart explants. Co-electroporation with a plasmid expressing GFP allowed us to trace which cells were successfully transfected. (B) Transcript levels of miR-200b in embryonic heart explants from WT1Cre-YFP mice after premiR, antimiR and scramble-control transfections. Error bars indicate SD. n = 3. Each point represents the mean of three technical replicates. Statistical analysis was performed using a one-way ANOVA followed by Dunnett´s multiple comparisons test. (C) Immunostaining for FLNA in electroporated heart explants. The boundary between the epicardium and the myocardium has been delineated with a dotted line. For a clearer view, FLNA-staining is shown in both magenta and gray scale. Scale bars, 50 μm. (D) Quantification of corrected FLNA fluorescence intensity. Error bars indicate SD. n = 3–5. Each point displayed in the graph represents a single quantified image obtained from independent biological samples. Each colour represents an independent biological replicate. Statistical analysis was performed using the biological sample as the unit of analysis; with measurements from multiple images per sample averaged prior to comparison. Differences among groups were assessed by one-way ANOVA followed by Dunnett´s multiple comparisons test. Finally, to determine whether FLNA mediates the regulation of symmetric versus asymmetric divisions, we performed FLNA loss-of-function experiments using siRNA-mediated knockdown in embryonic heart explants (Fig. 6A,B). In agreement with the effects of miR-200b overexpression, FLNA silencing led to a significant reduction in asymmetric divisions (Fig. 6C,D). Thus, FLNA depletion recapitulates the miR-200b phenotype, highlighting a critical role for FLNA in promoting asymmetric division in epicardial cells. FLNA loss-of-function compromises the number of asymmetric cell divisions in the epicardium. (A) Schematic overview of the experimental workflow. Hearts from mouse embryos at E12.5 were isolated and transfected with scramble or FLNA siRNA after 24 h of explant cultures. Cy5 co-transfection allowed us to trace which cells were successfully transfected. After 24 h of co-transfection, cultured embryonic heart explants were collected and quantitative real-time PCR (RT-qPCR) as well as Aurora B immunostaining were performed. (B) Quantification of FLNA mRNA expression levels in Scramble and FLNA siRNA transfected embryonic heart explants. Error bars indicate SD. n = 3. Statistical analysis was performed using the unpaired Student’s T-test. (C) Representative images of symmetric (dashed arrow) or asymmetric (arrows) cell division, Aurora B staining, in epicardial cells of heart sections from siFLNA transfected explants. Aurora B staining was used to define spindle orientation and GFP-expression to identify siFLNA transfected cells. The basement membrane is delineated by a dotted line marking the boundary between the epicardial layer and the subepicardium and outer myocardium. The basement membrane was considered 0° and is represented by the black dotted line. Each line corresponds to the spindle orientation of a dividing epicardial cell. Divisions with spindle orientations between 30° and 330° were classified as symmetric, whereas those between 60° and 120° were classified as asymmetric. The double-headed arrows indicate the orientation of the spindle. Scale bars: 25 μm. (D) Ratio of epicardial cell spindle orientation after FLNA loss-of-function experiments in embryonic heart explants. Error bars indicate SD. n = 3. Proportions of symmetric and asymmetric divisions in the FLNA siRNA experimental group were compared against those observed in the scramble control group. Statistical analysis was performed using the unpaired Student’s T-test. Together, these results demonstrate that miR-200b modulates epicardial cell division dynamics by post-transcriptionally repressing FLNA, thereby influencing the balance between symmetric and asymmetric divisions during heart development. miR-200b expression is altered after myocardial infarction in the mouse and human It has been demonstrated that following experimental myocardial infarction (MI) in mice, the remote epicardium retains its epithelial morphology, whereas the epicardium in the infarcted region undergoes significant epithelial-to-mesenchymal transition (EMT)33. Given that miR-200b regulates EPDC emergence in the developing epicardium, we sought to investigate whether miR-200b expression could also be reactivated in the adult heart following MI. RT-qPCR analysis of bulk cardiac tissues from mice subjected to experimental MI revealed that miR-200b expression is upregulated between 3 and 14 days post-MI, coinciding with the period during which epicardial EMT occurs in the infarcted myocardium (Fig. 7A,B)33. Importantly, we also observed altered miR-200b levels in the peripheral blood of patients following MI (Fig. 7C,D). Collectively, these findings suggest that miR-200b may play a role after MI. miR-200b expression is re-activated after MI in the adult heart. (A) Schematic overview of the experimental workflow. Hearts from infarcted and sham-operated mice were collected at different time points (days 1, 3, 7, and 14 post-infarction) for RNA isolation and quantitative real-time PCR (RT- qPCR) assays. (B) Quantification of miR-200b expression in bulk cardiac tissues from sham-operated and infarcted hearts at multiple time points after MI. A significant increase in miR-200b expression was observed in the infarcted region at day 7 post-infarction. Statistical analysis was performed using Fisher’s Least Significant Difference (LSD) test. (C) Schematic illustration of the experimental workflow. Serum samples were collected from infarcted and non-infarcted (control) human patients, and RNA isolation and quantitative real-time PCR (RT-qPCR) were performed to evaluate the expression of hmiR-200b in peripheral blood. (D) Box plot showing hmiR-200b expression levels in control and infarcted human serum samples. A significant reduction in miR-200b expression was observed in infarcted patients compared to controls. Statistical analysis was performed using the unpaired Student’s T-test (*p = 0.021). Discussion The contribution of the epicardium to heart development is a highly complex process that depends on the precise coordination of cell proliferation and differentiation. Epithelial-to-mesenchymal transition (EMT) represents a pivotal event through which epicardial cells lose polarity, migrate into the myocardium as epicardium-derived cells (EPDCs), and differentiate into distinct cardiac lineages during development and repair34. Proper cardiac morphogenesis and/or remodeling requires a finely tuned balance within the epicardial layer between cell motility and the preservation of epithelial integrity. However, the molecular signals and mechanisms that maintain this balance remain poorly understood. Here, we identify a previously unrecognized miR-200b–FLNA pathway that modulates cell division orientation, thereby defining epithelial dynamics during EPDC formation. During mouse development, the embryonic epicardium is considered “active” between embryonic days E11.5 and E15.5, a period characterized by intense proliferative activity and successiveregion-specific waves of EMT that generate epicardium-derived mesenchymal cells10,35,36. Although miR-200b has been widely described as an EMT inhibitor and tumor suppressor37,38, our previous findings indicated that miR-200b does not affect EMT marker expression in the epicardium25. Several studies have shown that, among the many miRNAs with critical developmental functions, members of the miR-200 family—including miR-200b—are enriched in epithelial tissues and contribute to maintaining epithelial phenotypes, as observed during lung development13,39–41. Here, we report that miR-200b expression appears to be activated in a subset of epithelial epicardial cells at the onset of EPDC emergence (E12.5). The proportion of miR-200b+ cells increases as EPDC formation progresses toward completion (E15.5), but its expression is no longer detectable once EPDC generation has concluded. Moreover, gain-of-function experiments revealed that miR-200b impairs EPDC formation. Collectively, these findings suggest that miR-200b regulates epithelial dynamics during EPDC genesis. Consistent with this, other studies have reported that several miR-200 family members are expressed in the developing heart between E11.5 and E15.518, coinciding with the temporal window in which we detect epicardial miR-200b expression. While previous analyses were performed at the whole-heart level without epicardial resolution, our results demonstrate, for the first time, the activation of miR-200b specifically within the epicardial layer—highlighting its potential role in regulating epithelial behaviour during EPDC development. Epicardial cell proliferation and spindle orientation are key determinants of cell ingression into the myocardium. Although β-catenin has been proposed to regulate epicardial polarity and spindle orientation, its reduction does not affect epicardial cell entry into the myocardium11. Consequently, the mechanisms that define which epicardial cells gain the capacity to generate EPDCs, while others remain attached are still poorly understood. Here, we show that modulating miR-200b expression significantly alters EPDC numbers. Because changes in miR-200b levels markedly shift the balance between symmetric and asymmetric divisions, our findings indicate that miR-200b is essential for maintaining the proper equilibrium of division modes within the epicardial layer, thereby ensuring correct EPDC formation, whether this effect is cell-autonomous remains to be determined. The observation that miR-200b expression peaks in the embryonic epicardium at E15.5 coinciding with predominant symmetric division, together with the increase in asymmetric division upon miR-200b loss of function and the expansion of symmetric division upon gain of function, supports the idea that miR-200b regulates the balance between maintenance of epicardial self-renewal and EPDC formation. High miR-200b expression at E15.5 may therefore mark the termination of EPDC generation. Mechanistically, our data identify miR-200b as a regulator of epicardial dynamics through direct repression of FLNA, a key mediator of asymmetric division. Although FLNA is classically associated with cytoskeletal organization and cell migration42,43, the cardiac malformations observed in Flna-null embryos—outflow tract anomalies and persistent truncus arteriosus—arise from defective development of epicardium-dependent structures such as the endocardial cushion, rather than impaired cell motility32,44. Combined with previous evidence linking FLNA to spindle positioning, these findings establish FLNA as a pivotal effector coupling cytoskeletal architecture to asymmetric division and EPDC formation in the epicardium. A growing body of evidence underscores the central role of epicardial biology in cardiac repair. Following myocardial injury, epicardial cells become reactivated, forming an expanded layer of EPDCs that differentiate into cardiac fibroblasts and contribute to coronary vessel formation45,46. As neovascularization and fibrosis are key processes in cardiac remodeling and heart failure progression, identifying molecular regulators of EPDC emergence is of significant interest for the development of novel therapeutic strategies. Notably, we found that miR-200b is upregulated in murine infarcted hearts. We further demonstrate that reactivated miR-200b expression occurs within the same temporal window during which EPDCs emergence has been reported in infarcted murine myocardium47–51. Additionally, changes in miR-200b levels were detected in the blood of myocardial infarction (MI) patients. However, as mouse data derive from whole cardiac tissue and the human data from peripheral blood, these findings do not directly resolve epicardial-specific regulation in the adult heart. Instead, they suggest a potential association between miR-200b dynamics and the cardiac injury response, consistent with a possible involvement of epicardial activation. Although decreased circulating levels of miR-200b have been reported in patients with chronic heart failure51, there is currently no evidence regarding its expression in the blood following acute injury. Given its reported involvement in inflammatory processes51, further investigations are needed to clarify the functional contribution of miR-200b to cardiac injury and subsequent repair mechanisms. This study has several limitations that should be considered. First, the identification and fate of epicardial cells and EPDCs were inferred based on WT1-Cre–YFP lineage tracing and anatomical positional criteria, which may not fully exclude contributions from other cell populations or definitively resolve lineage heterogeneity. Second, although FLNA was identified as a relevant target of miR-200b, we did not directly test whether FLNA is sufficient to recapitulate the observed phenotypes, nor whether its manipulation fully phenocopies the effects of miR-200b modulation. Third, post-MI analyses rely on bulk cardiac tissue in mice and circulating measurements in humans, limiting cellular resolution and rendering these findings correlative rather than causative. Despite these limitations, our findings provide a framework for understanding the miR–FLNA axis during cardiac development and suggest testable hypotheses for its potential involvement in cardiac injury and repair. In conclusion, we identify miR-200b as a critical regulator of EPDC formation, acting through FLNA to control division symmetry within the epicardium. We show that, in the activated epicardium, miR-200b–mediated repression of FLNA maintains epithelial integrity by restricting asymmetric divisions, whereas its downregulation permits EPDCs generation (Graphical Abstract). These findings uncover a previously unrecognized mechanism balancing epithelial cohesion and EPDCs emergence. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Acknowledgements We acknowledge Ramón Muñoz-Chapuli and Rita Carmona (University of Málaga) for kindly providing us with WT1Cre-YFP mice. Author contributions Conceptualization, A.E.A; Methodology, C.S.F, C.G.P, E.L.V, F.H.T, O.O, E.V., B.R.P, L.A.H and J.D.M; Writing- Original Draft, A.E.A and C.S.F; Writing-Review & Editing, A.E.A, C.S.F and J.D.M; Validation, C.S.F, C.G.P, E.L.V, F.H.T, A.Q, L.A.H, M.R, O.O and J.D.M; Formal Analysis, C.S.F, C.G.P, E.L.V, A.Q, L.A.H, M.R and J.D.M; Resources, R.C, A.Q, L.A.H and M.R; Funding Acquisition, M.R, D.F and A.E.A. Funding This work was supported by Grants to Amelia Aránega: PID2019-107492 GB-I00, ProyExcel_00513, PID2022-138163OB-C31 funded and Grants to M. Ricote: S2022/BMD-7227 Comunidad de Madrid, PID2021-122552OB-I00 and CNS2023-143622 funded by MICIN/AEI /10.13039/501100011033 and, by ERDF, EU, and European Union NextGenerationEU/PRTR. Data availability All the data needed to support the conclusions are present in this paper. Gene expression data has been deposited in Gene Expression Omnibus (GEO) repository-Series record GSE311233, and are available at the following URL: (https://www.ncbi.nlm.nih.gov/gds/?term=GSE311233) Nonetheless, any clarification about the support data will be made available upon request. Declarations Competing interests The authors declare no competing interests. Ethics approval and consent to participate The study was performed in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. It was approved by the Ethics Committee at the University of Jaen and the Hospital Universitario Virgen de las Nieves from Granada. Informed consent was obtained from all the participants. All the animal experiments complied with the ARRIVE guidelines. They were carried out in accordance with EU Directive 2010/63/EU for animal experiments and were approved by the Ethics Committee at the Universities of Jaen (UJA) and Granada (UGR). Consent for publication Written informed consent was obtained from all participants. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Jorge N. Domínguez, Email: jorgendm@ujaen.es Amelia E. Aránega, Email: aaranega@ujaen.es References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement All the data needed to support the conclusions are present in this paper. Gene expression data has been deposited in Gene Expression Omnibus (GEO) repository-Series record GSE311233, and are available at the following URL: (https://www.ncbi.nlm.nih.gov/gds/?term=GSE311233) Nonetheless, any clarification about the support data will be made available upon request.